{"id":8738,"date":"2020-06-03T15:27:00","date_gmt":"2020-06-03T19:27:00","guid":{"rendered":"https:\/\/vetanco.com\/en\/?p=8738"},"modified":"2024-12-04T10:09:31","modified_gmt":"2024-12-04T15:09:31","slug":"bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis","status":"publish","type":"post","link":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/","title":{"rendered":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis"},"content":{"rendered":"\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"277\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-1024x277.jpg\" alt=\"\" class=\"wp-image-8739\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-1024x277.jpg 1024w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-300x81.jpg 300w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-768x208.jpg 768w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-1536x415.jpg 1536w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-2048x554.jpg 2048w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/bioinnovo-logo-finalisimo-alta-510x138.jpg 510w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p><strong>Bioinnovo<\/strong>, the public-private company (<strong>INTA<\/strong>\u2013<strong>Vetanco<\/strong>) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are the Institute of Science and Technology C\u00e9sar Milstein (Conicet \u2013 Cassar\u00e1 Foundation), the Institute of Biosciences, Biotechnology and Transnational Biology (IB3 Faculty of Exact Sciences \u2013 University of Buenos Aires), the Malbr\u00e1n Institute and the INTA. Viviana Parre\u00f1o, Andr\u00e9s Wigdorovitz and\u00a0Marina Bok from INTA and Itat\u00ed Iba\u00f1ez from the Milstein Institute are members of the responsible group.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"638\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/20190701-cnia-mottaviani.jpg\" alt=\"\" class=\"wp-image-8740\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/20190701-cnia-mottaviani.jpg 960w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/20190701-cnia-mottaviani-300x199.jpg 300w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/20190701-cnia-mottaviani-768x510.jpg 768w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/20190701-cnia-mottaviani-510x339.jpg 510w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><figcaption class=\"wp-element-caption\"><em>Viviana Parre\u00f1o, INCUINTA, CICVyA, INTA Scientific Coordinator.<\/em><br><\/figcaption><\/figure>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"161\" height=\"108\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Logo-Exactas.png\" alt=\"\" class=\"wp-image-8741\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"131\" height=\"97\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Logo-Farmacia-y-Bioq.png\" alt=\"\" class=\"wp-image-8742\"\/><\/figure>\n<\/div>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"113\" height=\"89\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/LOGO-Milstein.png\" alt=\"\" class=\"wp-image-8743\"\/><\/figure>\n<\/div>\n\n\n\n<p>All these public institutions of the national science system joined forces to work together and, among them, Bionnovo participates contributing to the research of IgY neutralizing antibodies for the inhibition or the detection of this virus.<\/p>\n\n\n\n<p>The project, named&nbsp;<em>\u201cDevelopment and production of critical reagents for COVID-19 diagnosis and treatment: Nanobodies, IgY polyclonal antibodies and recombinant proteins\u201d<\/em>, develops the production of recombinant monoclonal nanobodies derived from camelids (VHHs), monoclonal antibodies from mice, polyclonal antibodies from egg yolk (IgY) and recombinant proteins, as critical supplies for the development of diagnosis and preventive and therapeutic treatments against COVID-19.<\/p>\n\n\n\n<p>The supplies produced will be made available to the entire Public Health and Science and Technology national system.<\/p>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"960\" height=\"640\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-1.jpeg\" alt=\"\" class=\"wp-image-8744\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-1.jpeg 960w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-1-300x200.jpeg 300w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-1-768x512.jpeg 768w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-1-510x340.jpeg 510w\" sizes=\"auto, (max-width: 960px) 100vw, 960px\" \/><figcaption class=\"wp-element-caption\"><em>The team integrated by researchers from INTA, Dr. Cesar Milstein Institute and University of Buenos Aires is focused on preventive and therapeutic treatments.<\/em><br><\/figcaption><\/figure>\n\n\n\n<p><strong>Great news, great pride.<\/strong><\/p>\n\n\n\n<p><strong>Bionnovo is INTA + Vetanco<\/strong><\/p>\n\n\n\n<div class=\"wp-block-group is-nowrap is-layout-flex wp-container-core-group-is-layout-ad2f72ca wp-block-group-is-layout-flex\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"205\" height=\"205\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/inta-logo-205x205-1.jpg\" alt=\"\" class=\"wp-image-8745\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/inta-logo-205x205-1.jpg 205w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/inta-logo-205x205-1-150x150.jpg 150w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/inta-logo-205x205-1-100x100.jpg 100w\" sizes=\"auto, (max-width: 205px) 100vw, 205px\" \/><\/figure>\n\n\n\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"190\" height=\"190\" src=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Isologo-Vetanco-190x190-1.jpg\" alt=\"\" class=\"wp-image-8746\" srcset=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Isologo-Vetanco-190x190-1.jpg 190w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Isologo-Vetanco-190x190-1-150x150.jpg 150w, https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Isologo-Vetanco-190x190-1-100x100.jpg 100w\" sizes=\"auto, (max-width: 190px) 100vw, 190px\" \/><\/figure>\n<\/div>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Bioinnovo, the public-private company (INTA\u2013Vetanco) made its first contribution to the macro collaborative project conducted by a scientific committee that brings together more than twenty male and female researchers from different institutions. Those institutions are the Institute of Science and Technology C\u00e9sar Milstein (Conicet \u2013 Cassar\u00e1 Foundation), the Institute of Biosciences, Biotechnology and Transnational Biology [&#8230;]\n","protected":false},"author":8,"featured_media":8747,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[28],"tags":[19,112,94,105,113,62,20,18],"class_list":["post-8738","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-bioinnovo","tag-cicvya","tag-conicet","tag-covid-19","tag-igy","tag-incuinta","tag-inta","tag-vetanco"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States<\/title>\n<meta name=\"description\" content=\"The supplies produced will be made available to the entire Public Health and Science and Technology national system.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States\" \/>\n<meta property=\"og:description\" content=\"The supplies produced will be made available to the entire Public Health and Science and Technology national system.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/\" \/>\n<meta property=\"og:site_name\" content=\"Vetanco United States\" \/>\n<meta property=\"article:published_time\" content=\"2020-06-03T19:27:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-12-04T15:09:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"960\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"julian\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"julian\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/\"},\"author\":{\"name\":\"julian\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/#\\\/schema\\\/person\\\/46afb38cfab0fe11bf52a9ded679bfcd\"},\"headline\":\"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis\",\"datePublished\":\"2020-06-03T19:27:00+00:00\",\"dateModified\":\"2024-12-04T15:09:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/\"},\"wordCount\":276,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vetanco.com\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Vivi-y-Marina-2.jpeg\",\"keywords\":[\"Bioinnovo\",\"CICVyA\",\"CONICET\",\"COVID-19\",\"IgY\",\"IncuINTA\",\"INTA\",\"Vetanco\"],\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/\",\"url\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/\",\"name\":\"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vetanco.com\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Vivi-y-Marina-2.jpeg\",\"datePublished\":\"2020-06-03T19:27:00+00:00\",\"dateModified\":\"2024-12-04T15:09:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/#\\\/schema\\\/person\\\/46afb38cfab0fe11bf52a9ded679bfcd\"},\"description\":\"The supplies produced will be made available to the entire Public Health and Science and Technology national system.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#primaryimage\",\"url\":\"https:\\\/\\\/vetanco.com\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Vivi-y-Marina-2.jpeg\",\"contentUrl\":\"https:\\\/\\\/vetanco.com\\\/en\\\/wp-content\\\/uploads\\\/2024\\\/09\\\/Vivi-y-Marina-2.jpeg\",\"width\":960,\"height\":640},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/vetanco.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/vetanco.com\\\/en\\\/\",\"name\":\"Vetanco United States\",\"description\":\"Safe Products for Safe Food\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vetanco.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vetanco.com\\\/en\\\/#\\\/schema\\\/person\\\/46afb38cfab0fe11bf52a9ded679bfcd\",\"name\":\"julian\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g\",\"caption\":\"julian\"},\"url\":\"https:\\\/\\\/vetanco.com\\\/en\\\/author\\\/julian\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States","description":"The supplies produced will be made available to the entire Public Health and Science and Technology national system.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/","og_locale":"en_US","og_type":"article","og_title":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States","og_description":"The supplies produced will be made available to the entire Public Health and Science and Technology national system.","og_url":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/","og_site_name":"Vetanco United States","article_published_time":"2020-06-03T19:27:00+00:00","article_modified_time":"2024-12-04T15:09:31+00:00","og_image":[{"width":960,"height":640,"url":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg","type":"image\/jpeg"}],"author":"julian","twitter_card":"summary_large_image","twitter_misc":{"Written by":"julian","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#article","isPartOf":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/"},"author":{"name":"julian","@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd"},"headline":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis","datePublished":"2020-06-03T19:27:00+00:00","dateModified":"2024-12-04T15:09:31+00:00","mainEntityOfPage":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/"},"wordCount":276,"commentCount":0,"image":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#primaryimage"},"thumbnailUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg","keywords":["Bioinnovo","CICVyA","CONICET","COVID-19","IgY","IncuINTA","INTA","Vetanco"],"articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/","url":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/","name":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis - Vetanco United States","isPartOf":{"@id":"https:\/\/vetanco.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#primaryimage"},"image":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#primaryimage"},"thumbnailUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg","datePublished":"2020-06-03T19:27:00+00:00","dateModified":"2024-12-04T15:09:31+00:00","author":{"@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd"},"description":"The supplies produced will be made available to the entire Public Health and Science and Technology national system.","breadcrumb":{"@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#primaryimage","url":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg","contentUrl":"https:\/\/vetanco.com\/en\/wp-content\/uploads\/2024\/09\/Vivi-y-Marina-2.jpeg","width":960,"height":640},{"@type":"BreadcrumbList","@id":"https:\/\/vetanco.com\/en\/bioinnovo-inoculated-first-batch-birds-rbd-receptor-binding-domain-protein-sars-cov-2-develop-igy-possible-use-treatment-diagnosis\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/vetanco.com\/en\/"},{"@type":"ListItem","position":2,"name":"Bioinnovo inoculated the first batch of birds with RBD (Receptor-Binding Domain) protein of SARS-CoV-2 to develop IgY for a possible use in treatment and diagnosis"}]},{"@type":"WebSite","@id":"https:\/\/vetanco.com\/en\/#website","url":"https:\/\/vetanco.com\/en\/","name":"Vetanco United States","description":"Safe Products for Safe Food","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vetanco.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/vetanco.com\/en\/#\/schema\/person\/46afb38cfab0fe11bf52a9ded679bfcd","name":"julian","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bc79426ed0651bb3545f906602e15ffcf6e4bdb7b02b2394b18705841d207f29?s=96&d=mm&r=g","caption":"julian"},"url":"https:\/\/vetanco.com\/en\/author\/julian\/"}]}},"_links":{"self":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/comments?post=8738"}],"version-history":[{"count":1,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8738\/revisions"}],"predecessor-version":[{"id":8748,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/posts\/8738\/revisions\/8748"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/media\/8747"}],"wp:attachment":[{"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/media?parent=8738"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/categories?post=8738"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vetanco.com\/en\/wp-json\/wp\/v2\/tags?post=8738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}